peramivir IV, zanamivir IV, and higher oral oseltamivir (Tamiflu) doses for patients hospitalized with H1N1 flu
December 2009
You'll hear about peramivir IV, zanamivir IV, and higher oral oseltamivir (Tamiflu) doses for patients hospitalized with H1N1 flu.
Peramivir is an intravenous neuraminidase inhibitor similar to Tamiflu or Relenza.
Peramivir is not approved yet...but FDA is allowing emergency use for certain patients hospitalized with 2009 H1N1 influenza.
Upgrade now to access this resource
This content is not available under the subscriptions purchased by your organization, but you can add it on!
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.